Azafaros, a clinical-stage biotechnology company developing novel therapies for rare lysosomal storage disorders (LSDs), today announced that it will present at the 2025 BIO International Convention ...

LEIDEN, Netherlands--(BUSINESS WIRE)--#Adults--Azafaros ... including GM1 and GM2 gangliosidoses and Niemann-Pick disease type C (NPC). GM1 gangliosidosis and GM2 gangliosidosis (Tay-Sachs and ...

Chronic illnesses associated with age and other risk factors—like diabetes, stroke and autoimmune illnesses—have become more ...

[63] Assessing Disease Activity, Disease Severity & Cumulative Disease Damage in Childhood- & Adult-onset SLE Fewer patients die from lupus and there is an overall increased life expectancy.

Newer formulations are even more effective at preventing illnesses that commonly afflict seniors — perhaps even dementia.

The onset of disease can happen throughout the lifespan of an affected individual, from prenatal life through adulthood. Azafaros is a clinical-stage company founded in 2018 with a deep ...

A study led by the Sant Pau Research Institute (IR Sant Pau) has succeeded in describing, for the first time in detail, the ...

Using the PREVENT risk equation, one-fifth were at high risk over 10 years, rising to two-thirds over the next 30 years.

Changes in these factors can play a critical role in disease. Epigenetics involves genetic control by factors other than an individual's DNA sequence. Epigenetic changes can switch genes on or off ...

Mutism in older adults is not uncommon ... raising the possibility of conditions such as advanced Alzheimer's disease, Jacob-Creutzfeldt disease, frontotemporal dementias, and certain psychiatric ...

As part of our efforts to explore the experiences of LGBTQ adults and their families in the U.S., we conducted a series of interviews with 30 gay, lesbian and bisexual adults who are raising children ...